Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2015 Aug 21;14(2):287–294.e2. doi: 10.1016/j.cgh.2015.08.022

Table 4. Obstetric and neonatal outcomes in patients with LDoP.

Outcome ICP
N= 26
PE with liver dysfunction
N= 134
HELLP
N= 72
AFLP
N= 1
HG with liver dysfunction
N= 14
Total
N= 247
OBSTETRIC OUTCOMES
Cesarian section 4 (17%) 68 (51%) 34 (47%) 1 (100%) 1 (8%) 108 (44%)
Premature delivery 1 (4%) 75 (56%) 50 (70%) 1 (100%) 2 (14%) 129 (53%)
NEONATAL OUTCOMES
Infant death 0 1 (0.7%) 2 (3%) 1 (100%) 0 4 (1.6%)
Miscarriagea 0 2 (1.5%) 0 0 1 (7%) 3 (1%)
Stillbirth* 0 2 (1.5%) 0 0 0 2 (0.8%)
Overall fetal mortality rate 0 5 (4%) 2 (3%) 1 (100%) 1 (7%) 9 (4%)
NICU admission 0 42 (32%) 31 (44%) 1 (100%) 0 74 (31%)
RECURRENT LDoP
% subjects with recurrent LDoP 35% 10% 14% 0 36% 14%
% subsequent pregnancies with recurrent LDoP 63% (10/16) 12% (12/102) 17% (11/63) 0% (0/11) 64% (7/11) 21% (40/193)

Live delivery before 37 weeks gestation

a

Intrauterine death before 24 weeks gestation

*

Intrauterine death after 24 weeks gestation

Includes infant death, miscarriage and stillbirth